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Engagement of innate viral sensors elicits a robust antiviral program via the induction of type I
interferons (IFNs). Innate defense mechanisms against ssDNA viruses are not well deﬁned. Here, we
examine type I IFN induction and effectiveness in controlling a ssDNA virus. Using mouse embryonic
ﬁbroblasts (MEFs), we found that a murine parvovirus, minute virus of mice (MVMp), induced a delayed
but signiﬁcant IFN response. MEFs deﬁcient in mitochondrial antiviral signaling protein (MAVS) mounted
a wild-type IFN response to MVMp infection, indicating that RIG-I-dependent RNA intermediate
recognition is not required for innate sensing of this virus. However, MVMp-induced IFNs, as well
recombinant type I IFNs, were unable to inhibit viral replication. Finally, MVMp infected cells became
unresponsive to Poly (I:C) stimulation. Together, these data suggest that the MVMp efﬁciently evades
antiviral immune mechanisms imposed by type I IFNs, which may in part explain their efﬁcient
transmission between mice.
& 2013 Elsevier Inc. All rights reserved.Introduction
Most cell types in mammalian hosts detect viral infection via
cytosolic and nuclear pattern recognition receptors (PRRs), which
sense the nucleic acid products of viral replication. The RIG-I-like
receptors (RLRs), RIG-I (retinoic acid inducible gene-I) and MDA5
(melanoma differentiation-associated gene 5), are involved in
sensing cytosolic RNA species, and activation via the adapter
molecule MAVS leads to the production of type I IFNs, via IRF3,
and of pro-inﬂammatory cytokines, via NF-κB (Hornung et al.,
2006; Kato et al., 2005, 2006; Pichlmair et al., 2006). Viral DNA
species found within the cytosol and nucleus are known to be
detected by an ever-increasing group of PRRs, including RNA
polymerase (Pol) III (Ablasser et al., 2009; Chiu et al., 2009), DAI
(Takaoka et al., 2007), IFI16 (Unterholzner et al., 2010), and
LRRFIP1 (Yang et al., 2010), which lead to downstream production
of type I IFNs and pro-inﬂammatory cytokines in a cell- and
context-speciﬁc manner.
The parvoviruses are a group of non-enveloped, single-
stranded DNA viruses that infect a diverse range of species from
rodents to humans. Parvoviral infections are responsible for
signiﬁcant clinical burden in many of the affected species. For
instance, canine parvovirus and feline panleukopenia virus causell rights reserved.
i).signiﬁcant mortality in infected dogs (Goddard and Leisewitz,
2010) or cats (Truyen et al., 2009). There are a number of
parvoviruses that infect humans, including erythrovirus B19,
adeno-associated viruses, and the recently discovered human
bocaviruses 1–4 and human parvovirus PARV4 (Brown, 2010). In
humans, the best documented clinical manifestations occur with
parvovirus B19 infection and include ﬁfth disease, arthropathy,
transient aplastic crisis, persistent anemia, and hydrops fetalis
(Young and Brown, 2004). Infection with the prototype strain of
MVM (MVMp) is asymptomatic in newborn mice, where it can
only be detected by seroconversion, and non-pathogenic in adult
mice, indicating a high degree of adaptation to its natural host
(Kimsey et al., 1986).
Although, MVM has a high, RNA virus-like mutation rate, and
exists as multiple in vivo and culture-adapted strains that infect a
series of disparate or overlapping differentiated host cell types
in vitro and in vivo (Cotmore and Tattersall, 2007), the prototype
MVMp strain exhibits a pronounced tropism for ﬁbroblasts. A
recent report described activation of the innate immune response
in murine embryonic ﬁbroblasts (MEFs) infected with this virus
(Grekova et al., 2010). This study found that MEFs from wild-type
C57BL/6 and CD1 mice robustly produced type-I IFNs and upre-
gulated anti-viral genes, such as protein kinase R (PKR) and 2′–5′
oligoadenylate synthetase (OAS), in response to MVMp infection
(Grekova et al., 2010).
Here, we examined the role of MAVS, which is involved in the
detection of RNA Pol III-synthesized RNA intermediates in
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We further probed the relevance of type I IFNs in the antiviral
protection against MVMp infection. The results of this study
suggest that parvovirus MVMp efﬁciently evades antiviral immune
mechanisms imposed by type I IFNs in this cell type.Results
MVMp infection in murine embryonic ﬁbroblasts leads to delayed and
limited activation of the IFN response
To examine the innate immune response to MVMp, we infected
MEFs with MVMp and performed a time course experiment, which
measured type I IFN mRNA induction by RT-qPCR during the ﬁrst
72 h. Typical infection efﬁciency at this time point was around 30%
(data not shown). We found a small, but statistically signiﬁcant
upregulation of IFN-α and IFN-β, especially at time points later than
48 h post infection (Fig. 1A). Consistent with these data, we found
activation of STAT1, as measured by its phosphorylation, at later time
points in MVMp-infected MEFs (Fig. 1B). The IFN response induced
by MVMp infection occurred much later and was smaller in
magnitude when compared to that following vesicular stomatitis
virus (VSV) infection. These results demonstrated that MVMp infec-
tion in MEFs activates a delayed but measurable IFN response.
RNA pol III-dependent stimulation of the MAVS signaling pathway is
not involved in the IFN response to MVMp in MEFs
We next tested whether MVMp infection results in the generation
of RNA Pol III-dependent RNA recognized by RLRs. AT-rich DNA
converted to 5′-triphosphate RNAs by RNA Pol III was used as a
positive control. These RNAs activate RIG-I, which results in IFN
production through downstream signaling via MAVS (Ablasser et al.,
2009; Chiu et al., 2009). To test whether MVMp genomic DNA is able
to stimulate the RNA Pol III pathway, we used HEK-293T cells, which
are only able to induce IFNs in response to Poly (dA:dT) DNA through
the RNA Pol III pathway (Ablasser et al., 2009; Chiu et al., 2009).
These cells were transfected with a reporter plasmid that expresses
luciferase under control of the IFN-β promoter. The cells were then
transfected with genomic DNA puriﬁed from MVMp virions. Calf
thymus DNA and Poly (dA:dT) DNA were used as negative andFig. 1. MVMp activates a delayed and minor interferon response in MEFs. Wild-type MEF
indicated time points and IFNa or IFNb mRNA levels were measured by RT-qPCR. (B)
subjected to SDS-PAGE followed by Western blotting for phospho-STAT1.positive controls, respectively. When the cells were analyzed for
luciferase activity, we found that transfection with MVMp genomic
DNA failed to activate the IFN-β promoter in HEK-293T cells, whereas
Poly (dA:dT) activated IFN-β robustly in these cells (Fig. 2A). These
results indicate that the RNA Pol III-dependent IFN pathway is not
activated by MVMp genomic DNA in HEK-293T cells.
Next, we examined whether MVMp-infected MEFs generate an
RNA species capable of stimulating IFN through the MAVS signaling
pathway. To this end, we infected wild-type MEFs with MVMp and
puriﬁed total RNA from cellular extracts after 48 h. The puriﬁed RNAs
were then used to transfect TLR7-deﬁcient bone marrow cells. These
cells were chosen to avoid contributions from TLR7 while probing
the ability of cytosolic RNA sensors to detect puriﬁed RNA from
MVMp infected cells. We found that TLR7-deﬁcient bone marrow
cells did not produce IFN-α (Fig. 2B) or IFN-β (Fig. 2C) in response to
RNAs isolated by MVMp-infected cells beyond the level seen from
RNAs isolated from uninfected cells. In contrast, the RNAs isolated
from VSV-infected cells induced robust production of IFN-α and IFN-β
in transfected TLR7-deﬁcient bone marrow cells, as previously
described (Kato et al., 2008). These results suggest that immunosti-
mulatory RNAs are not produced in MVMp-infected MEF.
It remained possible that immunostimulatory RNAs are
produced in MVMp-infected MEFs but remain undetectable in
our assays. To further probe whether immunostimulatory RNAs
stimulate type I IFNs in MVMp-infected MEFs, we examined
MAVS-deﬁcient MEFs. MAVS-deﬁcient MEFs infected with MVMp
generated IFN-α mRNA levels equivalent to wild-type MEFs, as
measured by RT-qPCR 48 h post-infection (Fig. 2D). In addition,
STAT1 phosphorylation in MAVS-deﬁcient MEFs upon infection
with MVMp was comparable to that seen upon infection of wild-
type MEFs, further demonstrating that MAVS is not involved in the
innate immune response to MVMp in MEFs (Fig. 2e). Taken
together, these data suggest that the RNA-sensing pathways are
not activated upon MVMp infection in MEFs.MVMp infection is not blocked by type I IFNs
Next, we examined whether the low levels of secreted IFNs can
actively inhibit MVMp infection of MEFs. First we examined IFN
synthesis upon MVMp infection in IFN-αβR-deﬁcient MEFs. Since
IFN-α production is controlled by a positive feedback loop throughs were infected with MVMp (MOI 1) or VSV (MOI 1). (A) Cells were collected at the
Cells were collected at the indicated time points, and lysates (in duplicate) were
Fig. 2. The RNA Pol III-dependent stimulation of the MAVS signaling pathway is not involved in the IFN response to MVMp in MEFs. (A) HEK-293T cells were transiently
transfected with an IFNβ-luciferase reporter plasmid. They were then stimulated with calf thymus DNA, Poly (dA:dT), or MVMp genomic DNA (all at 1 μg/ml). Luciferase
levels were measured after 24 hours. The levels are reported as fold change over mock-treated cells. (B) Wild-type MEFs were infected with VSV (MOI 1) or MVMp (MOI 1) or
left uninfected. Twenty-four hours later, total cellular RNAs were puriﬁed from the cells and then 50 μg of each was transfected into TLR7-deﬁcient bone marrow cells. Cells
were collected after eight hours, and IFNα and IFNβmRNA levels were quantiﬁed by RT-qPCR. (C, D) Wild-type or MAVS-deﬁcient MEFs were infected with MVMp (MOI 1) or
transfected with Poly (I:C) (PIC) (1 μg/ml). Cells were collected after 48 hours and IFNαmRNA levels were measured by RT-qPCR (C). Cells were collected at the indicated time
points, and lysates were subjected to SDS-PAGE followed by Western blotting for phospho-STAT1. (D) The relative intensity of the pSTAT1 band normalized to the β-actin
band is indicated.
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the IFN-αβR-deﬁcient MEFs would be reduced compared to wild-
type MEFs if they were responding to even low levels of secreted
IFNs. However, we found that the low levels of both IFN-α and IFN-β
mRNA produced by MEFs of either genotype were comparable for
the ﬁrst 48 h of infection (Fig. 3A). Although by 72 h there was a
slight decrease in the levels of IFN mRNAs produced in the IFN-αβR-
deﬁcient MEFs compared to the wild-type cells, the levels of IFN-α
and IFN-β remained below the limit of detection by ELISA throughout
infection (data not shown). These results suggest that there is
minimal feed-forward signaling through the IFNαβR, and this only
occurs at a very late time point, likely reﬂecting the very low levels of
IFN being produced by infected cells.
Next we asked if viral replication is affected by signaling though
the IFN-αβR. Signaling though the IFN-αβR leads to expression ofhundreds of interferon-stimulated genes (ISGs), inducing an antiviral
state in neighboring cells (Sen, 2001). As expected, replication of VSV,
a virus that is sensitive to type I IFNs (Ito and Montagnier, 1977), was
enhanced in the IFN-αβR-deﬁcient MEFs (Fig. 3b). In contrast, MVMp
replicated approximately equally well in both wild-type and IFN-αβR-
deﬁcient MEFs. These results suggest that the low levels of type I IFNs
produced during MVMp infection of MEFs are not sufﬁcient to induce
an antiviral state in the cell culture.
Exogenous IFN-β has minimal effect on MVMp infection
In vivo, many cell types other than ﬁbroblasts are capable of
secreting large amounts of type I IFNs in response to virus infections.
To test whether exogenous type I IFNs suppress MVMp replication in
MEFs, we pretreated wild-type and IFN-αβR-deﬁcient MEFs for
Fig. 3. Signaling through the IFNαβR does not affect MVMp replication in MEFs. (A) Wild-type or IFNαβR-deﬁcient MEFs were infected with MVMp (MOI 1) and IFNα and IFNβ
mRNA levels were quantiﬁed after eight hours by RT-qPCR. (B) Wild-type or IFNαβR-deﬁcient MEFs were infected with MVMp (MOI 1) or VSV-GFP (MOI 0.1) and were
collected at the indicated time points. The percentage of infected cells in the culture was measured by ﬂow cytometry.
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them with MVMp. We found that initiation of infection by MVMp
was only minimally affected by the addition of IFN-β in wild-type
cells (Fig. 4A). This is in contrast to the results we see upon infection
with VSV, where IFN-β pretreatment of wild-type, but not IFN-αβR-
deﬁcient, cells leads to the almost complete absence of VSV infection
in the cell culture (Fig. 4B). In order to conﬁrm these ﬁndings, we
extended the duration of infection up to 48-hours and measured the
extent of infection in target cells derived from wild-type, MAVS KO,
and IFN-αβR KO mice pretreated with recombinant IFN-β (Fig. 4C).
These data consistently demonstrated that exogenous type I IFN fails
to protect MEFs from MVMp infection, and that deﬁciencies in MAVS
or IFN-αβR does not impact MVMp replication. Thus, these data
demonstrate that exogenous IFN is not able to prevent MVMp
infection, and suggest that MVMp may have a mechanism to
counteract IFN-induced host antiviral effector mechanisms.
MVMp infection blocks cytokine production by poly (I:C)
Thus far, our results indicated that MVMp blocks IFN-induced
host antiviral defense mechanisms. However, it remains unclear if
MVMp is also capable of blocking the RLR signaling pathway in
infected cells. To test this hypothesis, we ﬁrst infected wild-type
MEF cells with two-fold dilutions of MVMp for 24 h and then
stimulated the cells for an additional 24 h by transfecting them
with Poly (I:C), a ligand for MDA5 (Gitlin et al., 2006; Kato et al.,
2006). Cell supernatants were collected and the levels of secreted
IFN-α and IL-6 were measured by ELISA (Fig. 5A). We found a
signiﬁcant, dose-dependent reduction in the amount of IFN and
cytokine secreted by the cells that had been pre-exposed to MVMp
compared to those that were uninfected before Poly (I:C) stimula-
tion. To determine whether the decrease in Poly (I:C) response is
due to apoptosis of MVMp-infected cells (Mincberg et al., 2011),
we performed a TUNEL staining assay on the cells after stimula-
tion. We found that approximately ﬁve percent of the cells were
TUNEL positive after the maximum dose of MVMp (Fig. 5B).However, this level of cell death in the MVMp-infected cultures
is unlikely to be solely responsible for the reduction in the amount
of cytokines secreted (approximately 40% reduction at the highest
MOI). We next used ﬂow cytometry to examine whether MVMp
infection can block cytokine production in response to Poly (I:C)
stimulation in a cell-autonomous manner. In this assay, cells were
ﬁrst infected for 24 h with MVMp. They were then transfected
with Poly (I:C) for eight hours, before being stained for intracel-
lular IL-6 and MVMp NS1 and analyzed by ﬂow cytometry.
Notably, we found that IL-6 expression in response to Poly (I:C)
stimulation was excluded from the NS1+ MVMp-infected popula-
tion (Fig. 5C). These data show that MVMp-infected cells are
unable to produce IL-6, suggesting that MVMp is able to block
activation of the innate response in a cell-autonomous manner.Discussion
Fibroblasts, like most cells, use cytosolic and nuclear PRRs to
detect direct viral infection via the sensing of viral nucleic acid
replication intermediates. We found that MVMp induces low
levels of type I IFNs in MEFs with delayed kinetics, consistent
with previous reports (Grekova et al., 2010; Schlehofer et al., 1992).
However, no evidence for RNA Pol III-mediated synthesis of RNA
intermediates that trigger the MAVS-dependent pathway was
found in MVMp-infected cells. Further, IFN induction in MVMp-
infected cells occurred independently of the presence of the MAVS
gene. Even though MVMp induces type I IFNs in infected cells, we
show that the low levels of type I IFNs generated late after
infection by MEFs are not sufﬁcient to induce an effective antiviral
state. This was demonstrated by the fact that MVMp replicated in
IFNαβR-deﬁcient MEFs at levels equivalent to wild-type cells,
while even pretreatment with high levels of exogenous IFNβ was
not able to signiﬁcantly block MVMp infection in wild-type MEFs.
Further, we provide evidence that MVMp is able to block the
innate immune response to another infection-mimicking stimulus
Fig. 4. Pretreatment of MEFs with exogenous IFNβ minimally inhibits MVMp
replication. (A) Wild-type or IFNαβR-deﬁcient MEFs were pretreated with the
indicated amounts of recombinant IFNβ for 18 hours before infection with MVMp
(MOI 1). The percentage of infected cells in the culture was measured after 24 h by
ﬂow cytometry after intracellular staining for NS1. (B) Wild-type or IFNαβR-
deﬁcient MEFs were pretreated with the indicated amounts of recombinant IFNβ
for 18 h before infection with VSV-GFP (MOI 0.1). The percentage of infected cells in
the culture was measured after 12 hours by ﬂow cytometry after intracellular
staining for NS1. (C) Wild-type, MAVS-deﬁcient, and IFNαβR-deﬁcient MEFs were
pretreated for 24 h with 250 U/ml of recombinant IFNβ and then infected with
MVMp (MOI 1). The percentage of infected cells in the culture was measured at the
indicated points by ﬂow cytometry after intracellular staining for NS1.
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reduced secretion of IFN and IL-6 from Poly (I:C)-stimulated MEFs
in a dose-dependent manner, and ﬂow cytometric analysis showed
that MVMp-infected MEFs were unable to produce IL-6 in
response to Poly (I:C) stimulation in a cell autonomous manner.
Overall, our results indicate that MVMp elicits delayed and low
levels of type I IFNs through a MAVS-independent mechanism, but
the virus is not susceptible to the effects of type I IFNs, and that
MVMp suppresses the cellular response to an exogenous Poly (I:C)
stimulus in a cell autonomous manner.
These results are somewhat at variance with those of Ventoso
and colleagues (Ventoso et al., 2010), who found that MVMp
infection of NIH3T3 cells and of primary MEFs prepared from the129Sv strain of mice, was restricted primarily through the activa-
tion of the cytosolic sensor double-stranded RNA-dependent
protein kinase R (PKR), and that resistance to infection correlated
with phosphorylation of eukaryotic translation factor 2α (eIF2 α).
These authors also showed that RNA transcribed in vitro from
genomic MVM DNA would stimulate PKR-dependent phosphor-
ylation of eIF2α. At present, we do not understand the basis of the
apparent discrepancies between our results and those of Ventoso
et al. (2010) but it should be noted that here we used exclusively
MEFs derived from C57BL/6 mice, and signiﬁcant differences in
susceptibility of different mouse strains, including C57BL/6 and
129Sv, to MVMp have been reported previously (Brownstein et al.,
1991).
An obvious question that arises from the present report
concerns the nature of the innate sensor(s) that recognize MVMp
within infected C57BL/6 embryonic ﬁbroblasts. Since the MAVS-
dependent pathway is dispensable for MVMp recognition in MEFs,
cytosolic or nuclear sensors of viral DNA, rather than viral mRNA,
are likely involved. Current evidence suggests that during produc-
tive infection the MVM genome transits the endosomal and
cytosolic compartment securely sequestered within the capsid,
and is uncoated in the nucleus upon the host cell's entry into
S-phase (Cotmore and Tattersall, 2007). However, if some MVM
genomes are exposed during transit of the cytosol, DNA sensors
that could detect them in this locale include DAI, LRRFIP1, IFI16, or
the putative ISD sensor (Stetson and Medzhitov, 2006). Engage-
ment of LRRFIP1 with dsDNA induces type I IFNs, but whether the
ssDNA viral genome would stimulate this molecule is unknown
(Yang et al., 2010). DAI is not activated by ssDNA (Stetson and
Medzhitov, 2006), and ISD is only known to be activated by dsDNA
(Stetson and Medzhitov, 2006). However, the MVMp genome does
have small regions of dsDNA that form its 3′ and 5′ hairpin
telomeres, making it possible that either DAI or ISD sensors might
be engaged during viral entry.
Perhaps more signiﬁcantly, this virus replicates in the cell
nucleus via a unidirectional strand displacement mechanism that
generates linear duplex replicative forms of the viral DNA, as well
as replicative intermediates containing extensive regions of single-
stranded DNA (Cotmore and Tattersall, 2012). Based on the
delayed IFN production in MVMp-infected cells, which mirrors
the viral replication kinetics, we suspect that viral ligands recog-
nized by the DNA sensor are likely derived from this ampliﬁed
viral replicative-form DNA. These unique DNA molecules may
present potential targets for intranuclear DNA sensor such as
IFI16, which is now known to detect DNA molecules in both the
cytoplasm and nucleus, having recently been shown to detect
Kaposi Sarcoma-Associated Herpesvirus (KSHV) DNA speciﬁcally
in the nuclear compartment (Kerur et al., 2011). However, a
previous report suggests that one MVMp sensing pathway is only
active in non-transformed cells (Grekova et al., 2010), which might
suggest involvement of the ISD sensor in its innate recognition
(Stetson and Medzhitov, 2006). It will be of considerable interest
in the future to determine which, if any, of these sensors are
involved in the innate recognition of nuclear viral DNA in
parvovirus-infected cells.
Conﬂicting results have been reported regarding the sensitivity
of MVMp to IFNs. Some reports found that MVMp is sensitive to
exogenous IFNs (Grekova et al., 2010; Harris et al., 1974), while
others showed no effect of IFN treatment on MVMp replication
(Engers et al., 1981). We found a very moderate effect of recombi-
nant IFN-β on MVMp infection, even at very large doses (Fig. 4).
In addition, IFN induced by MVMp infection was completely
ineffective in preventing viral replication (Fig. 3). The reasons for
these differences are not known, but may be due to differences in
the mouse strains or cell types examined, the time course of IFN
treatment and infection, or the MVM strain used. We speciﬁcally
Fig. 5. MVMp infection blocks interferon and cytokine production by Poly(I:C) stimulation. (A, B) Wild-type MEF cells were infected with MVMp (MOI 0.1, 0.3, or 1) for 24 h
before stimulation with Poly(I:C) (1 μg/ml). (A) Cell supernatants were collected after 24 h and the levels of secreted IFNα and IL-6 were measured by ELISA. (B) Cells were
collected after 24 h and the percentage of TUNEL+ apoptotic cells in the cultures was measured by ﬂow cytometry. Wild-type MEFs were infected with MVMp (MOI 1) for
24 h before stimulation with Poly (I:C) (1 μg/ml). Cells were analyzed for intracellular levels of MVMp NS1 (x-axis) and IL-6 (y-axis) by ﬂow cytometry. (C) Wild-type MEFs
were infected with MVMp (MOI 1) for 24 h before stimulation with Poly (I:C)(1 μg/ml). Cells were analyzed for intracellular levels of MVMp NS1 (x-axis) and IL-6
(y-axis) by ﬂow cytometry.
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avoid an impaired type I IFN response reported in transformed
cells in response to MVMp infection (Grekova et al., 2010). We
suspect that the extent of the block in IFN responses we observed
with MEFs is therefore further ampliﬁed in transformed cells.
Notwithstanding these differences, our data showed that MVMp
can evade antiviral activities imposed by type I IFNs. Since STAT-1
phosphorylation still occurs in MVMp-infected cells (Fig. 1), we
suspect that MVMp interferes with the activity of ISGs that
otherwise restrict viral replication.
Our data indicated that poly (I:C)-induced MDA5 signaling is
blocked in MVMp-infected cells, although the mechanism of this
blockade is unknown. Somewhat similarly, a recent study showed
that the NS2 protein of porcine parvovirus is able to block poly I:C-
induced IFN responses (Lin et al., 2013). The molecular size and
expression levels of the MAVS protein remain intact following
MVMp infection (unpublished observations), suggesting that the
blockade occurs downstream of MAVS. Based on the fact that
MVMp fails to elicit a rapid and effective type I IFN program in
MEFs and blocks further response to a secondary stimulus, we
propose that this immune evasion strategy may contribute to the
replication and spread of rodent autonomous parvoviruses in vivo.
In addition, MVMp infected cells may be particularly susceptible to
co-infection with RNA viruses, as the RLR signaling pathway is
clearly impaired. In addition to its well-known roles in Fifth
disease, arthropathy, transient aplastic crisis, persistent anemia,
and hydrops fetalis, human parvovirus B19 has been implicated in
a variety of human autoimmune diseases, including Hashimoto's
thyroidosis and rheumatoid arthritis (Lunardi et al., 2008). Given
the importance of parvovirus infection in humans and animals,
future elucidation of the viral evasion mechanisms may shed light
on proper treatment options for parvovirus-associated diseases.Materials and methods
Mice
Six- to seven-week old female C57BL/6 mice were obtained
from the National Cancer Institute. The MAVS-deﬁcient mice were
a kind gift from Zhijian Chen (UT Southwestern, Dallas, TX) (Sun
et al., 2006). TLR7-deﬁcient (Lund et al., 2004), IFNαβR-deﬁcient
(Hwang et al., 1995) and MAVS-deﬁcient (Sun et al., 2006) mice
were bred and housed in the animal facilities at Yale University.
MAVS-deﬁcient mice were maintained as heterozygotes to obtain
wild-type littermate controls. All procedures used in this study
complied with federal guidelines and institutional policies of the
Yale Animal Care and Use Committee.Viruses
Wild-type MVMp virions were generated by transfecting an
infectious plasmid clone into A9 cells, or co-transfecting into HEK-
293T cells with pXX6-80, a helper plasmid encoding the VA, E2A
and E4 regions of adenovirus (Xiao et al., 1998). Transfected and
infected cells were grown for 72 h, and virus then released by
subjecting the cells to three freeze–thaw cycles in 50 mM Tris–HCl,
0.5 mM EDTA, pH 8.7 (TE 8.7) containing protease inhibitors. The
cellular extract was cleared by centrifugation and puriﬁed on
iodixanol step gradients as previously described (Cotmore and
Tattersall, 2012; Farr et al., 2006). Virus titer (PFU/ml) was
quantiﬁed by plaque assay in A9 cells. Recombinant-derived
wild-type VSV and VSV-GFP was kindly provided by John Rose
(Yale University, New Haven, CT). VSV was propagated in BHK cells
as previously described (Lund et al., 2004).
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Murine embryonic ﬁbroblasts (MEFs) were prepared from day
14.5 embryos from C57BL/6, IFNαβR-deﬁcient mice, and MAVS-
deﬁcient and WT littermate control mice (Sun et al., 2006). MEFs
were used at passage 2–5 and were maintained in complete
DMEM medium (10% FBS, 10 mM HEPES, 100 units/ml penicillin
and 100 μg/ml streptomycin). Single-cell bone marrow suspen-
sions were prepared from cells isolated from the femurs and tibias
of mice and were maintained in complete RPMI medium. HEK-
293T cells were purchased from ATCC and were maintained in
complete DMEM medium. A9 ouabr11 cells were maintained in
complete DMEM medium (Tattersall and Bratton, 1983).
Cell stimulation
MEFs were plated at 8104 cells per well in 6-well tissue
culture plates in 2 ml of total medium. Cells were stimulated with
Poly (I:C) (1 μg/ml, Invivogen) or Poly (dA:dT) (1 μg/ml, Invivogen)
or genomic DNA extracted from puriﬁed MVMp virions (1 μg/ml)
complexed with Lipofectamine 2000 (Invitrogen) in OPTIMEM.
The transfection mediumwas replaced with fresh complete DMEM
after one hour. Cells were infected with recombinant wild-type
VSV or VSV-GFP (MOI 0.1–5) or infected with MVMp (MOI 0.1–1).
In some instances, cells were pretreated with recombinant IFN-β
(250 or 750 U/ml) (PBL IFN Source) for 18 hours before infection.
Cells were collected after 6–12 h for analysis by RT-qPCR and
supernatants were collected after 18–24 h for analysis by ELISA.
Cells used for intracellular cytokine staining were exposed to
Brefeldin A (Sigma-Aldrich) after 8 h of Poly (I:C) stimulation,
and harvested after a further ten hours.
Quantitative real time PCR
Total RNA was isolated from cells using an RNeasy Mini kit
(QIAGEN, Inc.) according to the manufacturer's protocol. RNA was
reverse transcribed using Superscript II and Oligo dT primers
(Invitrogen), and the resulting cDNA quantiﬁed on an MX3000p
instrument (Stratagene (Aligent Technologies, Inc.) using SYBR
Green-based assays (QIAGEN, Inc.) and primers listed in Table 1.
Western Blots
MEFs were trypsinized on ice, spun down, and resuspended in
RIPA lysis buffer (1% NP-40, 20 mM Tris, pH 7.5, 150 mM NaCl, 1x
protease inhibitor cocktail (Roche)). Proteins were separated by
SDS-PAGE on 4–20% precast gels (Bio-Rad Laboratories) and
transferred to a nitrocellulose membrane. The membranes were
blocked in 5% nonfat dry milk in a buffer containing 20 mM Tris,
pH 7.5, 500 mM NaCl, and 0.05% Tween 20, and incubated in anti-
phospho-STAT1 antibody (1:1000, Tyr701, Cell Signaling Technol-
ogy) or anti-β-actin antibody (1:5000, Sigma-Aldrich) diluted in
0.01 M Tris HCl, 0.15 M NaCl, 0.05% Tween-20 (TBST) containing 5%
bovine serum albumin. Membranes were washed, incubated with
goat anti-rabbit-HRP (for phosphoStat1, 1:50,000, Santa Cruz
Biotechnology) or goat anti-mouse-HRP (for β-actin, 1:10,000)Table 1
Primers used for quantitative RT-PCR.
IFNα4 forward CTGCTACTTGGAATGCAACTC
IFNα4 reverse CAGTCTTGCCAGCAAGTTGG
IFNb forward GCACTGGGTGGAATGAGACTATTG
IFNb reverse TTCTGAGGCATCAACTGACAGGTCdiluted in TBST plus 5% nonfat dry milk. Blots were developed
using SuperSignal West Femto enhanced chemiluminescent sub-
strate (Thermo Fisher Scientiﬁc). The levels of phosphoSTAT1 were
normalized to β-actin levels by measuring band intensity using the
program “Fiji” (Schindelin et al., 2012).IFN-β luciferase assay
HEK-293T cells were transiently transfected with an IFN-β-
luciferase reporter (300 ng/ml) using Lipofectamine 2000 (Invitro-
gen). Twenty-four hours later, cells were stimulated with calf
thymus DNA, Poly (dA:dT), or MVMp genomic DNA (all at 1 μg/ml)
using Lipofectamine 2000. Twenty-four hours later, cells were
washed once in PBS, and processed using a Dual-Luciferase
Reporter Assay (Promega) according to the manufacturer's instruc-
tions. Samples were read on a Lumat LB 9507 luminometer.ELISA
Levels of murine IFN-α were measured using ELISA as pre-
viously described (Lund et al., 2003). Brieﬂy, 96-well Maxisorp
plates (Nunc) were coated with rat anti-mouse IFN-α (F18 anti-
body, Hycult Biotech, Inc.) at a 1:100 dilution in carbonate buffer
overnight at 4 1C. After non-speciﬁc binding was blocked using
blocking buffer (5% FBS in PBS), samples were loaded at 1:2 in
blocking buffer. Recombinant IFN-α standards (Hycult Biotech,
Inc.) were also diluted in blocking buffer. After incubating samples
overnight at 4 1C or 4 h at room temperature, plates were
incubated in polyclonal rabbit anti-mouse IFN-α (PBL IFN Source)
at a 1:500 dilution in blocking buffer for 2 h at room temper-
ature. Plates were then incubated with horseradish peroxidase-
conjugated donkey anti–rabbit F(ab′)2 (Jackson ImmunoResearch
Laboratories) at 1:10,000 dilution in blocking buffer for one hour
at room temperature. The IL-6 ELISA was performed using a kit
according to the manufacturer's instructions (BioLegend). All ELISA
plates were developed with the addition of TMB (eBioscience, Inc.)
and the reaction was stopped by addition of 2NdH2SO4. The optical
density at 450 nm was measured using a Model 680 Microplate
reader (Bio-Rad Laboratories) and the concentration of cytokines
calculated from the appropriate standard curve.Flow cytometric analysis
MVMp-infected MEFs were trypsinized on ice, spun down, and
ﬁxed in FAC-Fix buffer (1% FBS and 1% paraformaldehyde in PBS)
for 20–30 min on ice. Cells were washed twice with FACS buffer
(1% FBS in PBS) and permeablized by the addition of intracellular
FACS (iFACS) buffer (1% FBS and 0.1% saponin in PBS). Cells were
stained in 96-well U-bottom tissue culture plates with anti-NS1
(1:50, CE10B10, (Yeung et al., 1991)) and/or anti-IL-6-PE (1:200,
MP5-20F3, eBioscience, Inc.) antibodies in a 50 μl volume of iFACS
buffer for 30 min on ice, before being washed twice with iFACS
buffer and then incubated with an anti-mouse secondary antibody
conjugated to Alexa Fluor 488 (1:500, A11001, Invitrogen). After
washing twice with iFACS buffer and once with FACS buffer, cells
were resuspended in FACS-Fix buffer. MEFs that had been infected
with VSV-GFP were trypsinized on ice, spun down, and then
resuspended in FACS-Fix buffer. Apoptotic cells were stained using
an In Situ Cell Death Detection Kit according to the manufacturer's
instructions (Roche). All cells were processed on a FACSCalibur
(BD Biosciences) and the results were analyzed using FlowJo
(TreeStar, Inc.)
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